U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H13N4O2S.Na
Molecular Weight 300.312
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFAMETHAZINE SODIUM

SMILES

[Na+].CC1=CC(C)=NC([N-]S(=O)(=O)C2=CC=C(N)C=C2)=N1

InChI

InChIKey=NGIVTUVVBWOTNT-UHFFFAOYSA-N
InChI=1S/C12H13N4O2S.Na/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11;/h3-7H,13H2,1-2H3;/q-1;+1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C12H14N4O2S
Molecular Weight 278.33
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm061367.pdf | https://www.drugs.com/vet/sulfamethazine-25-solution-can.html

Sulfamethazine is a sulfonamide used to treat a variety of bacterial diseases in animals. It inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase (dihydrofolate synthetase).

CNS Activity

Curator's Comment: Sulfamethazine, a lipid-soluble, and poorly ionized drug of low molecular weight has been found to penetrate the blood-brain barrier differently in various species of animals and at different stages of brain development

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
SULMET

Approved Use

INDICATIONS FOR USE Turkeys For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. In turkeys for control of coccidiosis (Eimeria meleagrimitis, Eimeria adenoeides). Medicate for 2 days, then reduce amount of medication to one-half for 4 additional days. Chickens For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. In chickens for control of infectious coryza (Avibacterium paragallinarum), coccidiosis (Eimeria tenella, Eimeria necatrix), acute fowl cholera (Pasteurella multocida), and pullorum disease (Salmonella Pullorum). Medicate as follows: Infectious coryza, medicate for 2 consecutive days; acute fowl cholera and pullorum disease, medicate for 6 consecutive days; coccidiosis, medicate for 2 days, then reduce amount of medication to one-half for 4 additional days. Cattle (beef and nonlactating dairy) For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. Treatment of bacterial pneumonia and bovine respiratory disease complex (shipping fever complex) (Pasteurella species), colibacillosis (bacterial scours) (Escherichia coli), necrotic pododermatitis (foot rot) (Fusobacterium necrophorum), calf diphtheria (Fusobacterium necrophorum), acute metritis (Streptococcus species), and acute mastitis in beef cattle (Streptococcus species). Swine For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. For treatment and control of diseases caused by organisms to sulfamethazine. Treatment of porcine colibacillosis (bacterial scours) (Escherichia coli), and bacterial pneumonia (Pasteurella species).
Curative
SULMET

Approved Use

INDICATIONS FOR USE Turkeys For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. In turkeys for control of coccidiosis (Eimeria meleagrimitis, Eimeria adenoeides). Medicate for 2 days, then reduce amount of medication to one-half for 4 additional days. Chickens For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. In chickens for control of infectious coryza (Avibacterium paragallinarum), coccidiosis (Eimeria tenella, Eimeria necatrix), acute fowl cholera (Pasteurella multocida), and pullorum disease (Salmonella Pullorum). Medicate as follows: Infectious coryza, medicate for 2 consecutive days; acute fowl cholera and pullorum disease, medicate for 6 consecutive days; coccidiosis, medicate for 2 days, then reduce amount of medication to one-half for 4 additional days. Cattle (beef and nonlactating dairy) For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. Treatment of bacterial pneumonia and bovine respiratory disease complex (shipping fever complex) (Pasteurella species), colibacillosis (bacterial scours) (Escherichia coli), necrotic pododermatitis (foot rot) (Fusobacterium necrophorum), calf diphtheria (Fusobacterium necrophorum), acute metritis (Streptococcus species), and acute mastitis in beef cattle (Streptococcus species). Swine For treatment and control of the following diseases caused by the following pathogenic organisms susceptible to sulfamethazine. For treatment and control of diseases caused by organisms to sulfamethazine. Treatment of porcine colibacillosis (bacterial scours) (Escherichia coli), and bacterial pneumonia (Pasteurella species).
Doses

Doses

DosePopulationAdverse events​
40 mg/kg single, oral
Highest studied dose
Dose: 40 mg/kg
Route: oral
Route: single
Dose: 40 mg/kg
Sources:
healthy
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer

Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
yes
Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
yes [Ki 476 uM]
PubMed

PubMed

TitleDatePubMed
Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA.
2006-05-15
A method for the quantification of low concentration sulfamethazine residues in milk based on molecularly imprinted clean-up and surface preconcentration at a Nafion-modified glassy carbon electrode.
2006-02-13
Proteomic analysis using an unfinished bacterial genome: the effects of subminimum inhibitory concentrations of antibiotics on Mannheimia haemolytica virulence factor expression.
2005-12
Monitoring of five sulfonamide antibacterial residues in milk by in-tube solid-phase microextraction coupled to high-performance liquid chromatography.
2005-11-02
Effects of mannan oligosaccharide and an antimicrobial product in nursery diets on performance of pigs reared on three different farms.
2005-11
Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS- and ATP-dependent pathways.
2005-10-20
Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues.
2005-10
Dispersive solid-phase extraction for the determination of sulfonamides in chicken muscle by liquid chromatography.
2005-09-16
Preparation and evaluation of uniform-sized molecularly imprinted polymer beads used for the separation of sulfamethazine.
2005-09
Confirmation of sulfamethazine, sulfathiazole, and sulfadimethoxine residues in condensed milk and soft-cheese products by liquid chromatography/tandem mass spectrometry.
2005-07-09
Surface runoff and transport of sulfonamide antibiotics and tracers on manured grassland.
2005-07-07
[Qualification and quantification of 10 sulfonamides in animal feedstuff by high performance liquid chromatography-electrospray tandem mass spectrometry].
2005-07
Photocatalytic oxidation of sulfamethazine.
2005-07
Cross-coupling of sulfonamide antimicrobial agents with model humic constituents.
2005-06-15
Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment.
2005-06
[Effect of starvation and acetone on the enzyme systems of biotransformation and toxicity of xenobiotics--CYP2E1 substrates in rats].
2005-05-25
Triplet-sensitized photodegradation of sulfa drugs containing six-membered heterocyclic groups: identification of an SO2 extrusion photoproduct.
2005-05-15
Microbial inhibition by pharmaceutical antibiotics in different soils--dose-response relations determined with the iron(III) reduction test.
2005-04
Different behavior of tetracyclines and sulfonamides in sandy soils after repeated fertilization with liquid manure.
2005-04
Test-plot studies on runoff of sulfonamides from manured soils after sprinkler irrigation.
2005-04
European Proficiency testing of national reference laboratories for the confirmation of sulfonamide residues in muscle and milk.
2005-03
Use of sulfonamides in layers in Kampala district, Uganda and sulfonamide residues in commercial eggs.
2005-03
Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
2005-01-15
Attenuation of gonadal response to photostimulation following ablation of neurons in the lateral septal organ of chicks.
2005-01-15
[Effect of sulphamethazine on the gene expression of FRTL-5 cells].
2005-01
Effects of sub-minimum inhibitory concentration antibiotic levels and temperature on growth kinetics and outer membrane protein expression in Mannheimia haemolytica and Haemophilus somnus.
2005-01
Effect of agricultural antibiotics on the persistence and transformation of 17beta-estradiol in a Sequatchie loam.
2005
Determination of sulfonamide residues in the tissues of food animals using automated precolumn derivatization and liquid chromatography with fluorescence detection.
2004-10-21
Administration of and withdrawal periods for sulphadimidine solution.
2004-09-18
Quantitative analysis of twelve sulfonamides in honey after acidic hydrolysis by high-performance liquid chromatography with post-column derivatization and fluorescence detection.
2004-08-20
Antibiotic residues in edible tissues and antibiotic resistance of faecal Escherichia coli in pigs from Portugal.
2004-08
Chemometric and derivative methods as flexible spectrophotometric approaches for dissolution and assaying tests in multicomponent tablets.
2004-08
Sorption of sulfonamide pharmaceutical antibiotics on whole soils and particle-size fractions.
2004-07-16
Prediction of chronic liver diseases on the basis of the N-acetyltransferase 2 phenotype.
2004-07-16
Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy.
2004-06
Validation of a confirmatory method for the determination of sulphonamides in muscle according to the European Union regulation 2002/657/EC.
2004-04-02
Quantitative assessment of the reliability of identification by high-performance liquid chromatography-mass spectrometry.
2004-03-26
[Determination of the residues of five sulfa drugs in eel by HPLC].
2004-03
Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.
2004-03
Antimicrobial use in the treatment of calf diarrhea.
2004-02-10
Automated microarray system for the simultaneous detection of antibiotics in milk.
2004-02-01
Sulfamethazine advances puberty in male chicks by effecting a rapid increase in gonadotropins.
2004-02
[Determination of the hereditary and constitutive predisposition to peritoneal commissures].
2004
Quantitative determination of trace concentrations of tetracycline and sulfonamide antibiotics in surface water using solid-phase extraction and liquid chromatography/ion trap tandem mass spectrometry.
2004
Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography-tandem mass spectrometry.
2003-12-22
Bioconcentration and elimination of sulfamethazine and its main metabolite in sturgeon (Acipenser schrenkii).
2003-12-17
3-Aminophenol as a novel coupling agent for the spectrophotometric determination of sulfonamide derivatives.
2003-12
[Determination of sulfamethazine and sulfamethoxazole in muscle of chicken by high performance liquid chromatography].
2003-11
Routine monitoring of antibiotics in water and wastewater with a radioimmunoassay technique.
2003-04-07
[Rheological and biopharmaceutical investigation of polymer drug delivery systems].
2003
Patents

Sample Use Guides

Administer in drinking water to provide: Chickens 58 to 85 milligrams of sulfamethazine sodium per pound of body weight per day; turkeys 50 to 124 milligrams of sulfamethazine sodium per pound of body weight per day; depending upon the dosage, age, and class of chickens or turkeys, ambient temperature, and other factors. Administer to cattle and swine in drinking water, or as a drench, to provide 108 milligrams of sulfamethazine sodium per pound of body weight on the first day and 54 milligrams of sulfamethazine sodium per pound of body weight per day on the second, third, and fourth days of administration.
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Minimum inhibitory concentrations (MICs) for antimicrobial agents including sulfamethazine were determined for 1570 bacterial isolates from turkey poults from eight geographic locations (1204 Escherichia coli, 231 other enteric gram-negative bacilli [including Citrobacter spp., Enterobacter spp., Klebsiella spp., Proteus spp., and Salmonella spp.], 31 Pseudomonas spp., 18 coagulase-positive staphylococci, 26 coagulase-negative staphylococci, and 55 streptococci and enterococci)
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:36:31 GMT 2025
Edited
by admin
on Mon Mar 31 17:36:31 GMT 2025
Record UNII
7Z13P9Q95C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SULFAMETHAZINE SODIUM
Common Name English
SULFADIMIDINE SODIUM
MART.   WHO-DD   WHO-IP  
Preferred Name English
N(SUP 1)-(4,6-DIMETHYL-2-PYRIMIDYL)SULFANILAMIDE SODIUM SALT
Common Name English
SULPHADIMIDINE SODIUM
Common Name English
SULFADIMIDINUM NATRICUM [WHO-IP LATIN]
Common Name English
Sulfadimidine sodium [WHO-DD]
Common Name English
SULFAMETHAZINE SODIUM SALT [MI]
Common Name English
N(SUP 1)-(4,6-DIMETHYL-2-PYRIMIDINYL)SULFANILAMIDE SODIUM SALT
Common Name English
4-AMINO-N-(4,6-DIMETHYL-2-PYRIMIDINYL)BENZENESULFONAMIDE SODIUM SALT
Common Name English
SULFAMETHAZINE SODIUM SALT
MI  
Common Name English
SODIUM SULFAMETHAZINE
Common Name English
SULFADIMIDINE SODIUM [WHO-IP]
Common Name English
SULFAMETHAZINE SODIUM [GREEN BOOK]
Common Name English
4,6-DIMETHYL-2-SULFANILAMIDOPYRIMIDINE SODIUM SALT
Common Name English
SULFADIMIDINE SODIUM [MART.]
Common Name English
N 1-(4,6-DIMETHYL-2-PYRIMIDINYL)SULFANILAMIDE MONOSODIUM SALT [WHO-IP]
Systematic Name English
BOVIBOL
Common Name English
INTRADINE
Common Name English
Classification Tree Code System Code
CFR 21 CFR 520.2261
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
NCI_THESAURUS C29739
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
Code System Code Type Description
PUBCHEM
13456556
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
RXCUI
1364374
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY RxNorm
SMS_ID
300000023779
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
FDA UNII
7Z13P9Q95C
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
CAS
1981-58-4
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
DAILYMED
7Z13P9Q95C
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
MERCK INDEX
m10317
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID70890551
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
DRUG BANK
DBSALT002199
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
NCI_THESAURUS
C84184
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
SULFAMETHAZINE SODIUM
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY Description: A white or creamy white, crystalline powder; odourless or almost odourless. Solubility: Soluble in 2.5 parts of water and in 60 parts of ethanol (~750 g/l) TS. Category: Antibacterial drug. Storage: Sulfadimidine sodium should be kept in a well-closed container, protected from light. Additional information: Even in the absence of light, Sulfadimidine sodium is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Definition: Sulfadimidine sodium contains not less than 98.0% and not more than 101.0% of C12H13N4NaO2S, calculated with reference to the dried substance.
ECHA (EC/EINECS)
217-840-0
Created by admin on Mon Mar 31 17:36:31 GMT 2025 , Edited by admin on Mon Mar 31 17:36:31 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY